[2-(ω-phenylalkyl)phenoxy]alkylamines II: Synthesis and selective serotonin-2 receptor binding

Chemical and Pharmaceutical Bulletin

Volumn 48, Issue 2, 2000, Pages 245-255

  Tanaka, Naoki ^a   Goto, Riki ^a   Ito, Rie ^a   Hayakawa, Miho ^a   Sugidachi, Atsuhiro ^a   Ogawa, Taketoshi ^a   Asai, Fumitoshi ^a   Fujimoto, Koichi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Antagonist; Antiplatelet; Serotonin 2 (5 HT2) receptor; 2 (2 phenylethyl)phenoxy alkylamines

Indexed keywords

2 [2 [2 [2 (3 METHOXYPHENYL)ETHYL]PHENOXY]ETHYL] 1 METHYLPYRROLIDINE; ALIPHATIC AMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; RAT; THROMBOCYTE AGGREGATION INHIBITION; VASOCONSTRICTION;

EID: 0034094593     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.48.245     Document Type: Article

References (28)

1. Present address: Patent Department, Sankyo Co., Ltd.
2. Villalón C. M., De Vries P., Saxena P. R., Drug Discovery Today, 2, 294-300 (1997).
3. Martin G. R., Humphrey P. P. A., Neuropharmacology, 33, 261-273 (1994).
4. Leysen J. E., Gommeren W., Van Gompel P., Wynants J., Janssen P. F. M., Laduron P. M., Mol. Pharmacol., 27, 600-611 (1985).
5. Kennis L. E. J., Vandenberk J., Boey J. M., Mertens J. C., Van Heertum A. H. M., Janssen M., Awouters F., Drug Dev. Res., 8, 133-140 (1986).
6. Blackburn T. P., Thornber C. W., Pearce R. J., Cox B., FASEB J., 2, A1404 (1988).
7. Shannon M., Battaglia G., Glennon R. A., Titeler M., Eur. J Pharmacol., 102, 23-29 (1984).
8. De Clerck F., David J.-L., Janssen P. A. J., Agents Actions, 12, 388-397 (1982).
9. Van Nueten J. M., Fed. Proc., 42, 223-227 (1983).
10. DeClerck F., Herman A. G., Fed. Proc., 42, 228-232 (1983).
11. De Clerck F., Van Nueten J. M., Reneman R. S., Agents Actions, 15, 612-626 (1984).
12. De Cree J., Leempoels J., Demon B., Roels V., Verhaegen H., Agents Actions, 16, 313-317 (1985).
13. Fozard J. R., J. Cardiovasc. Pharmacol., 4, 829-838 (1982).
14. Cohen M. L., Fuller R. W., Kurz K. D., Hypertension, 5, 676-681 (1983).
15. Hara H., Osakabe M., Kitajima A., Tamao Y., Kikumoto R., Thromb. Haemost., 65, 415-420 (1991).
16. Kikumoto R., Hara H., Ninomiya K., Osakabe M., Sugano M., Fukami H., Tamao Y., J. Med. Chem., 33, 1818-1823 (1990).
17. Tanaka N., Goto R., Ito R., Hayakawa M., Ogawa T., Fujimoto K., Chem. Pharm. Bull., 46, 639-646 (1998).
18. Mitsunobu O., Synthesis, 1981, 1 28.
19. Mancuso A. J., Huang S. L., Swern D., J. Org. Chem., 43, 2480-2482 (1978).
20. Fujimoto K., Tanaka N., Asai F., Ito T., Koike H., Eur. Pat. EP600717 (1994) [Chem. Abstr., 123, 169510k (1995)].
21. Leysen J. E., Niemegeers C. J. E., Van Nueten J. M., Laduron P. M., Mol. Pharmacology., 21, 301-314 (1982).
22. Köhler C., Hall H., Ögren S., Gawell L., Biochem. Pharmacol., 34, 2251-2259 (1985).
23. Greengrass P., Bremner R., Eur. J. Pharmacol., 55, 323-326 (1979).
24. U'Prichard D. C., Bylund D. B., Snyder S. H., J. Biol. Chem., 253, 5090-5102 (1978).
25. Middlemiss D. N., Eur. J. Pharmacol., 101, 289-293 (1984).
26. Kilpatrick G. J., Jones B. J., Tyers M. B., Nature (London), 330, 746-748 (1987).
27. Van Nueten J. M., Janssen P. A. J., Van Beek J., Xhonneux R., Verbeuren T. J., Vanhoutte P. M., J. Pharmacol. Exp. Ther., 218, 217-230 (1981).
28. Present address: Research Institute, Sankyo Co., Ltd.